As states continue to grapple with the growing challenge of drug-impaired driving, New York has emerged as a national leader by successfully implementing a statewide evidential oral fluid testing program. The program demonstrates that oral fluid can serve as a practical, scientifically reliable alternative to blood testing in many Driving Under the Influence of Drugs (DUID) investigations. For jurisdictions exploring ways to improve impaired-driving enforcement, New York’s experience offers important lessons.
Why Oral Fluid Matters
Traditional blood collection has long been considered the gold standard in impaired-driving investigations. However, obtaining blood samples often requires medical personnel, transportation to healthcare facilities, and compliance with complex legal requirements. These obstacles can delay sample collection and reduce the likelihood of capturing evidence of recent drug use.
Oral fluid testing addresses many of these challenges by offering:
- Rapid collection at roadside or during investigations
- Non-invasive sampling
- Collection by trained law enforcement officers rather than medical professionals
- Detection windows comparable to blood for many commonly encountered drugs
- Improved opportunities to capture evidence closer to the time of impairment
Recognizing these advantages, the New York State Police launched a pilot program in September 2023 before implementing a statewide evidential oral fluid program in July 2024.
The Pilot Program: Putting Oral Fluid to the Test
The pilot study collected 201 matched oral fluid and blood samples from suspected drug-impaired drivers. Researchers found an overall agreement rate of 96% between the two specimen types when evaluating drug detections.
Key findings included:
- 48% of paired samples produced exact compound-to-compound matches.
- Another 48% showed partial agreement.
- Only 4% failed to show any matching results.
- When parent drugs and metabolites were considered together, exact agreement increased to 59%.
These findings are consistent with prior research demonstrating strong correlations between oral fluid and blood in impaired-driving investigations.
Where Oral Fluid Outperformed Blood
One of the most compelling findings was oral fluid’s ability to identify recent drug use that was not detected in paired blood specimens.
Among the 201 paired samples:
- 93 cases contained additional positive findings in oral fluid.
- Only 22 cases contained additional findings in blood.
The greatest differences appeared in:
Heroin Use Detection
Researchers identified 21 cases where 6-acetylmorphine (6-AM), the unique metabolite of heroin, was detected in oral fluid but not in blood. No blood samples tested positive for 6-AM. This finding highlights oral fluid’s particular value in identifying recent heroin use.
Cocaine and Stimulants
Oral fluid frequently detected cocaine, benzoylecgonine, methamphetamine, and amphetamine when corresponding blood samples did not. Importantly, no cases showed stimulant detection in blood without corresponding evidence in oral fluid.
Cannabis
Cannabis findings reflected differing detection windows. Oral fluid often identified recent THC exposure, while blood more frequently captured inactive THC metabolites associated with prior use. This distinction may provide a clearer picture of recent consumption.
Program Implementation: More Than Just Science
While analytical performance is critical, New York’s success was equally dependent on stakeholder engagement and strategic planning.
Beginning in 2018, New York assembled traffic safety professionals, prosecutors, judges, toxicologists, law enforcement officers, and policymakers to discuss oral fluid testing. These collaborative efforts included:
- Statewide workshops
- Development of educational resources
- Prosecutor training
- Judicial outreach
- Drug Recognition Expert (DRE) training
- Pilot testing before full implementation
This coordinated approach helped build confidence in oral fluid evidence across the criminal justice system before statewide rollout.
Results from the First Year
The first year of the statewide program demonstrated strong adoption.
Between July 2024 and June 2025:
- 703 oral fluid cases were submitted.
- Oral fluid accounted for 27% of all toxicology submissions.
- Usage increased steadily throughout the year.
- Cases represented 48 counties across the state.
Researchers also observed a gradual reduction in the time between an incident and specimen collection. Median oral fluid collection times improved from 2 hours and 19 minutes during the first quarter to 1 hour and 35 minutes by the fourth quarter.
Lessons for Texas
Texas continues to face rising concerns about drug-impaired driving involving cannabis, opioids, prescription medications, and other impairing substances. As discussions continue around modernizing DUID investigations, New York’s model offers several important takeaways:
1. Start with a Pilot Program
Testing oral fluid alongside blood provides valuable local data and helps stakeholders gain confidence in the technology before broader implementation.
2. Engage Stakeholders Early
Success requires buy-in from prosecutors, judges, toxicologists, law enforcement leaders, traffic safety partners, and policymakers.
3. Focus on Timely Evidence Collection
Earlier collection can improve detection rates and strengthen the evidentiary value of toxicology results.
4. Use Oral Fluid as an Additional Tool
New York emphasizes that oral fluid is not intended to replace blood in all circumstances. Instead, it serves as a practical alternative in cases where blood collection presents challenges.
Looking Ahead
The New York State evidential oral fluid testing program demonstrates that oral fluid can be successfully integrated into impaired-driving investigations while maintaining scientific reliability and courtroom acceptance. With a 96% correlation rate between oral fluid and blood and strong statewide adoption, the program provides a compelling roadmap for jurisdictions seeking more efficient and accessible approaches to DUID enforcement.
As states continue searching for effective responses to drug-impaired driving, New York’s experience suggests that oral fluid testing may be one of the most promising tools available.
Source: Limoges, Abbott, McDonough, & Tracy, “New York State’s Evidential Oral Fluid Testing Program,” Journal of Forensic Sciences (2026).
